The drug acquisition curve: a method for the analysis and prediction of drug epidemiology
Related Experiment Video
Updated: Oct 21, 2026

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
Published on: October 16, 2015
Abstract:
A method is presented to chart how a group acquires exposure to a drug. The resulting drug acquisition curve has a number of different parameters that describe the group's drug involvement. Key parameters include: (1) the age of exposure when the group begins to use the drug in greater numbers, probably because of exposure to drug-using peers; (2) the acquisition rate, the percent of the group who are newly exposed each year, a rate that is surprisingly constant over as much as 5 years; and (3) the asymptote, establishing the total percent of the group who will eventually try the drug. Acquisition curves for sequential age cohorts show changing trends in these parameters and can also be used to predict future drug epidemiology. A 4-year prediction based on this method proved to be very accurate for two of three drugs. For the third drug, a large increase in use was predicted, but the increase was even greater than expected.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Related Concept Videos
Time Course of Drug Effect
Dose-Response Relationship: Overview
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
On the other hand, integral calculus focuses on...
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
Pharmacodynamic Models: Additive and Proportional Drug Effect Model